Background: Coronavirus disease (Covid-19) becomes a pandemic worldwide in 2020. Different dermatological manifestations associated with Covid-19 infection like maculopapular, morbilliform, urticarial, vesicular, chilblain-like, petechiae, purpura, and livedoid rashes. Pityriasis rosea (PR) and PR-like eruptions were recently reported to increase in coronavirus cases. Aim: To evaluate and review the literature on PR and PR-like eruption associated with Covid-19 disease. Case Report: A 24-year-old female patient presented with a history of asymptomatic PR-like eruption that started during infection with the Covid-19 virus and resolved spontaneously over 14 weeks without therapy. Conclusion: PR and PR-like eruptions are not uncommon with Covid-19 disease and could be the early manifestation of SARS-CoV-2 virus infection.
Litchman, G., Nair, P.A. and Le, J.K. (2022) Pityriasis Rosea. StatPearls Publishing, Treasure Island.
Drago, F., Ciccarese, G., Rebora, A., Broccolo, F. and Parodi, A. (2016) Pityriasis Rosea: A Comprehensive Classification. Dermatology (Basel, Switzerland), 232, 431-437. https://doi.org/10.1159/000445375
Leung, A., Lam, J.M., Leong, K.F. and Hon, K.L. (2021) Pityriasis Rosea: An Updated Review. Current Pediatric Reviews, 17, 201-211. https://doi.org/10.2174/1573396316666200923161330
Mahajan, K., Relhan, V., Relhan, A.K. and Garg, V.K. (2016) Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. Indian Journal of Dermatology, 61, 375-384. https://doi.org/10.4103/0019-5154.185699
VanRavenstein, K. and Edlund, B.J. (2017) Diagnosis and Management of Pityriasis Rosea. The Nurse Practitioner, 42, 8-11. https://doi.org/10.1097/01.NPR.0000511012.21714.66
Chuh, A., Lee, A., Zawar, V., Sciallis, G. and Kempf, W. (2005) Pityriasis Rosea—An Update. Indian Journal of Dermatology, Venereology, and Leprology, 71, 311-315. https://doi.org/10.4103/0378-6323.16779
Chhabra, N., Prabha, N., Kulkarni, S. and Ganguly, S. (2018) Pityriasis Rosea: Clinical Profile from Central India. Indian Dermatology Online Journal, 9, 414-417. https://doi.org/10.4103/idoj.IDOJ_12_18
Amer, A., Fischer, H. and Li, X. (2007) The Natural History of Pityriasis Rosea in Black American Children: How Correct Is the “Classic” Description. Archives of Pediatrics and Adolescent Medicine, 161, 503-506. https://doi.org/10.1001/archpedi.161.5.503
Zawar, V. (2010) Unilateral Pityriasis Rosea in a Child. Journal of Dermatological Case Reports, 4, 54-56. https://doi.org/10.3315/jdcr.2010.1057
Min, J.Y. and Jang, Y.J. (2012) Macrolide Therapy in Respiratory Viral Infections. Mediators of Inflammation, 2012, Article ID: 649570. https://doi.org/10.1155/2012/649570
Poddighe, D. and Aljofan, M. (2020) Clinical Evidence on the Antiviral Properties of Macrolide Antibiotics in the Covid-19 Era and Beyond. Antiviral Chemistry & Chemotherapy, 28, 2040206620961712. https://doi.org/10.1177/2040206620961712
Centers for Disease Control and Prevention (2021, December 21) Coronavirus Disease 2019 (Covid-19). https://www.cdc.gov/dotw/Covid-19/index.html
Seque, C.A., Enokihara, M.M., Porro, A.M. and Tomimori, J. (2022) Skin Manifestations Associated with Covid-19. Anais Brasileiros de Dermatologia, 97, 75-88. https://doi.org/10.1016/j.abd.2021.08.002
Genovese, G., Moltrasio, C., Berti, E. and Marzano, A.V. (2021) Skin Manifestations Associated with Covid-19: Current Knowledge and Future Perspectives. Dermatology (Basel, Switzerland), 237, 1-12. https://doi.org/10.1159/000512932
Singh, H., Kaur, H., Singh, K. and Sen, C.K. (2021) Cutaneous Manifestations of Covid-19: A Systematic Review. Advances in Wound Care, 10, 51-80. https://doi.org/10.1089/wound.2020.1309
Veraldi, S., Romagnuolo, M. and Benzecry, V. (2021) Pityriasis Rosea-Like Eruption Revealing Covid-19. The Australasian Journal of Dermatology, 62, e333-e334. https://doi.org/10.1111/ajd.13504
Merhy, R., Sarkis, A.S. and Stephan, F. (2021) Pityriasis Rosea Is a Leading Manifestation of Covid-19 Infection. Journal of the European Academy of Dermatology and Venereology: JEADV, 35, e246-e247. https://doi.org/10.1111/jdv.17052
Johansen, M., Chisolm, S.S., Aspey, L.D. and Brahmbhatt, M. (2021) Pityriasis Rosea in Otherwise Asymptomatic Confirmed Covid-19-Positive Patients: A Report of 2 Cases. JAAD Case Reports, 7, 93-94. https://doi.org/10.1016/j.jdcr.2020.10.035
Martora, F., Picone, V., Fornaro, L., Fabbrocini, G. and Marasca, C. (2022) Can Covid-19 Cause Atypical Forms of Pityriasis Rosea Refractory to Conventional Therapies. Journal of Medical Virology, 94, 1292-1293. https://doi.org/10.1002/jmv.27535
Öncü, I.N.S., Güler, D., Gürel, G. and Yalçın, G.Ş. (2021) Pityriasis Rosea in a Confirmed Covid-19 Pediatric Patient. Actas Dermo-Sifiliograficas, 112, 864-865. https://doi.org/10.1016/j.ad.2021.05.003
Martín Enguix, D., Salazar Nievas, M.D.C. and Martín Romero, D.T. (2020) Pityriasis Rosea Gibert Type Rash in an Asymptomatic Patient That Tested Positive for Covid-19. Medicina Clinica (English ed.), 155, 273. https://doi.org/10.1016/j.medcle.2020.05.017
Ehsani, A.H., Nasimi, M. and Bigdelo, Z. (2020) Pityriasis Rosea as a Cutaneous Manifestation of Covid-19 Infection. Journal of the European Academy of Dermatology and Venereology: JEADV, 34, e436-e437. https://doi.org/10.1111/jdv.16579
Drago, F., Ciccarese, G., Rebora, A. and Parodi, A. (2021) Human Herpesvirus-6, -7, and Epstein-Barr Virus Reactivation in Pityriasis Rosea during Covid-19. Journal of Medical Virology, 93, 1850-1851. https://doi.org/10.1002/jmv.26549
Sanchez, A., Sohier, P., Benghanem, S., L’Honneur, A.S., Rozenberg, F., Dupin, N. and Garel, B. (2020) Digitate Papulosquamous Eruption Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatology, 156, 819-820. https://doi.org/10.1001/jamadermatol.2020.1704
Paolino, G., Di Nicola, M.R., Cantisani, C. and Mercuri, S.R. (2021) Pityriasis Rosea Infection in a Covid-19 Patient Successfully Treated with Systemic Steroid and Antihistamine via Telemedicine: Literature Update of a Possible Prodromal Symptom of an Underlying SARS-CoV-2 Infection. Dermatologic Therapy, 34, e14972. https://doi.org/10.1111/dth.14972
Dursun, R. and Temiz, S.A. (2020) The Clinics of HHV-6 Infection in Covid-19 Pandemic: Pityriasis Rosea and Kawasaki Disease. Dermatologic Therapy, 33, e13730. https://doi.org/10.1111/dth.13730
Errichetti, E. and Stinco, G. (2016) Dermoscopy in General Dermatology: A Practical Overview. Dermatology and Therapy, 6, 471-507. https://doi.org/10.1007/s13555-016-0141-6
Elmas, Ö., Kilitçi, A. and Acar, E. (2019) Dermoscopic Profile of Pityriasis Rosea. Dermatologica Sinica, 37, 199-204. https://doi.org/10.4103/ds.ds_14_19
Galván Casas, C., Català, A., Carretero Hernández, G., et al. (2020) Classification of the Cutaneous Manifestations of Covid-19: A Rapid Prospective Nationwide Consensus Study in Spain with 375 Cases. British Journal of Dermatology, 183, 71-77.
Su, C.J. and Lee, C.H. (2020) Viral Exanthem in Covid-19, a Clinical Enigma with Biological Significance. The Journal of the European Academy of Dermatology and Venereology, 34, e251-e252. https://doi.org/10.1111/jdv.16469
Temiz, S.A., Dursun, R., Daye, M. and Ataseven, A. (2020) Evaluation of Dermatology Consultations in the Era of Covid-19. Dermatologic Therapy, 33, e13642. https://doi.org/10.1111/dth.13642
Estébanez, A., Pérez-Santiago, L., Silva, E., Guillen-Climent, S., GarcíaVázquez, A. and Ramón, M.D. (2020) Cutaneous Manifestations in Covid-19: A New Contribution. Journal of the European Academy of Dermatology and Venereology, 34, e250-e251. https://doi.org/10.1111/jdv.16474
Recalcati, S. (2020) Cutaneous Manifestations in Covid-19: A First Perspective. Journal of the European Academy of Dermatology and Venereology: JEADV, 34, e212-e213. https://doi.org/10.1111/jdv.16387
Drago, F., Broccolo, F. and Rebora, A. (2009) Pityriasis Rosea: An Update with a Critical Appraisal of Its Possible Herpesviral Etiology. Journal of the American Academy of Dermatology, 61, 303-318. https://doi.org/10.1016/j.jaad.2008.07.045
Broccolo, F., Drago, F., Careddu, A.M., Foglieni, C., Turbino, L., Cocuzza, C.E., Gelmetti, C., Lusso, P., Rebora, A.E. and Malnati, M.S. (2005) Additional Evidence Is That Pityriasis Rosea Is Associated with the Reactivation of Human Herpesvirus-6 and -7. The Journal of Investigative Dermatology, 124, 1234-1240. https://doi.org/10.1111/j.0022-202X.2005.23719.x
Drago, F., Ranieri, E., Malaguti, F., Battifoglio, M.L., Losi, E. and Rebora, A. (1997) Human Herpesvirus 7 in Patients with Pityriasis Rosea. Electron Microscopy Investigations and Polymerase Chain Reaction in Mononuclear Cells, Plasma, and Skin. Dermatology (Basel, Switzerland), 195, 374-378. https://doi.org/10.1159/000245991
Watanabe, T., Kawamura, T., Jacob, S.E., Aquilino, E.A., Orenstein, J.M., Black, J.B. and Blauvelt, A. (2002) Pityriasis Rosea Is Associated with Systemic Active Infection with both Human Herpesvirus-7 and Human Herpesvirus-6. The Journal of Investigative Dermatology, 119, 793-797. https://doi.org/10.1046/j.1523-1747.2002.00200.x
Mukai, T., Yamamoto, T., Kondo, T., Kondo, K., Okuno, T., Kosuge, H. and Yamanishi, K. (1994) Molecular Epidemiological Studies of Human Herpesvirus 6 in Families. Journal of Medical Virology, 42, 224-227. https://doi.org/10.1002/jmv.1890420303
Drago, F. and Rebora, A. (2003) Viral Reactivation and Skin Eruptions. Dermatology (Basel, Switzerland), 207, 1-2. https://doi.org/10.1159/000070931
Katsafanas, G.C., Schirmer, E.C., Wyatt, L.S. and Frenkel, N. (1996) In Vitro Activation of Human Herpesviruses 6 and 7 from Latency. Proceedings of the National Academy of Sciences of the United States of America, 93, 9788-9792. https://doi.org/10.1073/pnas.93.18.9788
Gianotti, R., Veraldi, S., Recalcati, S., Cusini, M., Ghislanzoni, M., Boggio, F. and Fox, L.P. (2020) Cutaneous Clinico-Pathological Findings in Three Covid-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy. Acta Dermato-Venereologica, 100, adv00124. https://doi.org/10.2340/00015555-3490